
IISc combines antibiotics to tackle drug-resistant TB
The story in brief
Isoniazid resistance poses a major challenge in the treatment of TB, but researchers at IISc have found that combining it with vancomycin significantly reduces bacterial burden. The study, conducted with the National Tuberculosis Institute, tested the combination against drug-resistant isolates, showing over 90% reduction in bacterial growth. PhD student Sukriti Pal highlighted the ongoing challenge of drug resistance in TB treatment.